Season of tumour detection influences factors predicting survival of patients with breast cancer (original) (raw)
References
Lee JAH: Seasonal alterations and the natural history of malignant neoplasms. Prog Clin Cancer 3: 96–106, 1967 PubMed Google Scholar
Jacobsen HK, Janerich DT: (Abstract) Seasonal variation in the diagnosis of breast cancer. Proc Am Assoc Cancer Res 18: 93, 1977 Google Scholar
Cohen P, Wax Y, Modan B: Seasonality in the occurrence of breast cancer. Cancer Res 43: 892–896, 1983 PubMed Google Scholar
Hartveit F, Thoresen S, Tangen M, Halvorsen JF: Variation in histology and oestrogen receptor content in breast carcinoma related to tumour size and time of presentation. Clin Oncol 9: 233–238, 1983 PubMed Google Scholar
Mason BH, Holdaway IM, Mullins PR, Kay RG, Skinner SJ: Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status. Breast Cancer Res Treat 5: 171–176, 1985 PubMed Google Scholar
Kirkham N, Machin D, Cotton DWK, Pike JM: Seasonality and breast cancer. Europ J Surg Oncol 11: 143–146, 1985 Google Scholar
Cohen P: (Abstract) Breast cancer prognosis and detection of the first symptom. Breast Cancer Res Treat 3: 311, 1983 Google Scholar
Mason BH, Holdaway IM, Kay RG, Stewart AW, Skinner SJ: Abstract Season of breast cancer detection and disease progression. NZ Med J 101: 268, 1988 Google Scholar
Hawkins RA, Roberts MM, Forrest APM: Oestrogen receptors and breast cancer: current status. Br J Surg 67: 153–169, 1980 PubMed Google Scholar
Fagnart OC, Cambiaso CL, Lejeune MD, Noel G, Maisin H, Masson PL: Prognostic value of concentration of pregnancy-specific beta 1-glycoprotein in serum of patients with breast cancer. Int J Cancer 36: 541–544, 1985 PubMed Google Scholar
McGuire WL: Prognostic factors in primary breast cancer. Cancer Surv 5: 527–536, 1986 PubMed Google Scholar
Dressler LG, Seamer LC, Owens MA, Clark GM, McGuire WL: DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens. Cancer 61: 420–427, 1988 PubMed Google Scholar
Sainsbury JRC, Farndon JR, Needham GK, Malcolm AJ, Harris AL: Epidermal growth factor status as predictor of early recurrence and death from breast cancer. Lancet 1: 1398–1402, 1987 PubMed Google Scholar
McNee RK, Mason BH, Neave LM, Kay RG: Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand. Breast Cancer Res Treat 9: 145–150, 1987 PubMed Google Scholar
Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D: Body size and survival in premenopausal breast cancer. Br J Cancer 51: 691–697, 1985 PubMed Google Scholar
Dowsett M, McGarrick GE, Harris AL, Coombes RC, Smith IE, Jeffcoate SL: Prognostic significance of serum prolactin levels in advanced breast cancer. Br J Cancer 47: 763–769, 1983 PubMed Google Scholar
Waseda N, Kato Y, Imura H, Kurata M: Prognostic value of oestrogen and prolactin receptor analysis in human breast cancer. Jpn J Cancer Res 76: 517–523, 1985 PubMed Google Scholar
Bonneterre J, Peyrat JP, Beuscart R, Lefebvre J, Demaille A: Prognostic significance of prolactin receptors in human breast cancer. Cancer Res 47: 4724–4728, 1987 PubMed Google Scholar
Adami HO, Malker B, Holmberg L, Persson I, Stone B: The relation between survival and age at diagnosis in breast cancer. N Engl J Med 315: 559–563, 1986 PubMed Google Scholar
H'st H, Lund E: Age as a prognostic factor in breast cancer. Cancer 47: 2217–2221, 1986 Google Scholar
Mason BH, Holdaway IM, Skinner SJ, Stewart AW, Kay RG, Neave LM, Anderson J: Association between season of first detection ot breast cancer and disease progression. Breast Cancer Res Treat 9: 227–232, 1987 PubMed Google Scholar
Holdaway IM: Principles of radioreceptor assays. In: Odell WD, Franchimont P (eds) Principles of Radioreceptor Assays. Wiley, New York, 1982, pp. 255–265 Google Scholar
Cox RD: Regression models and life tables (with discussion). J Roy Stat Soc (B) 34: 182–220, 1972 Google Scholar
Kennaway DJ, Gilmore TA, Seamark RF: Effect of melatonin feeding on serum prolactin and gonadotrophin levels and the onset of seasonal cyclicity in sheep. Endocrinology 110: 1766–1772, 1982 PubMed Google Scholar
Wright J, Aldhous M, Franey C, English J, Arendt J: The effects of exogenous melatonin on endocrine function in man. Clin Endocrinol 24: 375–382, 1986 Google Scholar
Touitou Y, Carayon A, Reinberg A, Bogdan A, Beck H: Differences in the seasonal rhythmicity of plasma prolactin in elderly human subjects: detection in women but not in men. J Endocrinol 96: 65–71, 1983 PubMed Google Scholar
Haus E, Lakatua DJ, Halberg F, Halberg E, Cornelissen G, Sackett LL, Berg HG, Kawasaki T, Ueno M, Uezono K, Matsuoka M, Omae T: Chronobiological studies of plasma prolactin in women in Kyushu, Japan, and Minnesota, USA. J Clin Endocrinol Metab 51: 632–640, 1980 PubMed Google Scholar
Wang DY, De Stavola BL, Bulbrook RD, Allen DS, Kwa HG, Gravelle IH: The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk — A population study of post-menopausal women. Europ J Cancer Clin Oncol 24: 1225–1231, 1988 PubMed Google Scholar
Musey VC, Delwood C, Collins C, Musey PI, Martino-Saltzman MS, Preedy JRK: Long-term effect of a first pregnancy on the secretion of prolactin. New Engl J Med 316: 229–234, 1987 PubMed Google Scholar
Brunning PF, Bonfrer JMG, Verstraeten AA: Prolactin levels after surgery (letter). N Engl J Med 6: 384–385, 1987 Google Scholar
Yu MC, Gerkins VR, Henderson BE, Brown JB, Pike MC: Elevated levels of prolactin in nulliparous women. Br J Cancer 43: 826–831, 1981 PubMed Google Scholar
Kwa HG, Bulbrook RD, Cleton F, Verstraeten AA, Hayward JL, Wang DY: An abnormal early evening peak of plasma prolactin in nulliparous and obese post-menopausal women. Int J Cancer 22: 691–693, 1978 PubMed Google Scholar
Meyer F, Brown JB, Morrison AS, MacMahon B: Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Nat Cancer Inst 77: 613–616, 1986 PubMed Google Scholar
Englesman E, Heuson JC, Blonk-Van der Wijst J, Drochmans A, Maass H, Cheix F, Sobrinho LG, Nowakowski H: Controlled clinical trial of L-dopa and nafoxidine in advanced breast cancer, an EORTC study. Br Med J 2: 714–715, 1975 PubMed Google Scholar
European Breast Cancer Group: Clinical trial of 2-Br-α-ergocryptine (CB154) in advanced breast cancer. Eur J Cancer 8: 155–156, 1972 Google Scholar
Holdaway IM, Friesen HG: Hormone binding by human mammary carcinoma. Cancer Res 37: 1946–1951, 1977 PubMed Google Scholar
Di Carlo R, Muccioli G: Prolactin receptor in human mammary carcinoma. Tumori 65: 695–702, 1979 PubMed Google Scholar
Schindler AE, Ebert E, Friedreich E: Conversion of androstenedione to estrone by human fat tissue. J Clin Endocrinol Metab 5: 627–630, 1972 Google Scholar
Onegan WL, Biedrzycki L: (Abstract) Obesity and oestrogen production in breast cancer patients. Cancer Treat Rep 63: 1204, 1979 Google Scholar
Shultz TD, Wilcox RB, Spuehler JM, Howie BJ: Dietary and hormonal interrelationships in premenopausal women: evidence for a relationship between dietary nutrients and plasma prolactin levels. Am J Clin Nutr 46: 905–911, 1987 PubMed Google Scholar
Van Staveren WA, Deurenberg P, Burema J, DeGroot LCPGM, Hautvast JGAJ: Seasonal variation in food intake, pattern of physical activity and change in body weight in a group of young adult Dutch women consuming self selected diets. Int J Obesity 10: 133–145, 1986 Google Scholar
Gordon DJ, Hyde J, Trost DC, Whaley FS, Hannan PJ, Jacobs DR, Ekelund L: Cyclic seasonal variation in plasma lipid and lipoprotein levels: the Lipid Research Clinic's coronary primary prevention trial placebo group. J Clin Epidemiol 41: 679–689, 1988 PubMed Google Scholar
Hrushesky W, Teslow T, Halberg F, Kiang D, Kennedy BJ: (Abstract) Temporal components of predictable variability along the 1-year scale in oestrogen receptor concentration of primary human breast cancer. ASCO 20 (C-165): 331, 1979 Google Scholar